Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

ROME Therapeutics
700 Main St.
Cambridge, MA 02139
https://rometx.com/

ROME Therapeutics is developing novel therapies for cancer and autoimmune diseases by harnessing the power of the repeatome - vast stretches of uncharted genetic material that have long been dismissed as 'junk DNA.' With several drug targets identified and multiple discovery programs underway, ROME is moving rapidly to leverage this new frontier in biology. To lead this exploration, ROME has assembled a team of world-class leaders across fields including oncology, immunology, virology and machine learning. ROME was launched in April 2020 and was incubated at GV, in collaboration with ARCH Venture Partners and Partners Innovation Fund.

Key Contact
Name
Rosana Kapeller
Title
CEO
Funding Events

Date
Amount
Type
Investors
Valuation
04/27/20 $50,000,000 Series A ARCH Venture Partners
Google Ventures
Partners Innovation Fund
undisclosed
10/13/23 $149,000,000 Series B Alexandria Venture Investments
Andreessen Horowitz
ARCH Venture Partners
Bristol Myers Squibb
Casdin Capital
Eurofarma Ventures
GV
Johnson & Johnson Development Corporation (JJDC)
Luma Group
Mass General Brigham Ventures
Mirae Asset Capital
Raycap
Sanofi Ventures
Section 32
Sigmas Group
undisclosed